Effects of a partnership support program for couples undergoing fertility treatment

From hope to hesitation: why couples fail to return for infertility treatment after the first consultation

STUDY QUESTION

What are the key factors that influence couples' decision not to return for fertility treatment after their first consultation?

SUMMARY ANSWER

Advanced maternal age, lower ovarian reserve, and eligibility for heterologous fertilization are primary determinants of non-return among couples.

WHAT IS KNOWN ALREADY

Previous research highlights the psychological, financial, and demographic reasons behind high dropout rates in IVF, yet a comprehensive understanding of the factors driving non-return, particularly at the first consultation, is still lacking and warrants further study.

STUDY DESIGN, SIZE, DURATION

This single-center observational study, incorporating both retrospective and prospective components, analyzed couples consulting at Humanitas Research Hospital from 2012 to 2021. The retrospective review spanned 24 773 couples from 2012 to 2021, among whom 6174 did not return. The prospective cohort included 986 couples who failed to return out of a total of 3214 couples who had their first consultation in 2021.

PARTICIPANTS/MATERIALS, SETTING, METHODS

Participants included couples seeking their first fertility consultation at a specialized fertility center. Retrospective data were extracted from internal records to assess personal, demographic, and biological factors (anti-Mullerian hormone [AMH] and FSH levels) contributing to non-return, while non-returning patients in the prospective arm completed a telephone questionnaire in addition to data extraction from internal records.

MAIN RESULTS AND THE ROLE OF CHANCE

Between 2012 and 2021, 24.92% of couples did not return after the initial consultation, with older age and diminished ovarian reserve as significant predictors. Of 3214 couples in 2021, 986 (30.68%) did not return after their first consultation. All 986 patients were contacted, and the response rate was 85.1%. Non-returning women were significantly older (37.1 vs. 35.6 years) and exhibited lower AMH levels (1.87 vs. 2.83 ng/ml) and higher FSH levels (13.13 vs. 8.19 mIU/ml). Primary reasons for non-return included eligibility for gamete donation (34.09%), spontaneous pregnancy (29.20%), and transferring treatment to another center (18.71%). Other contributing factors were existing parenthood (11.43%), psychological distress (9.65%), and dissatisfaction with the doctor (7.39%). These findings highlight the multifaceted nature of treatment discontinuation and underscore the importance of comprehensive support to mitigate non-return risk.

LIMITATIONS, REASONS FOR CAUTION

This study is limited by its single-center design: generalizability may vary based on differences in patient demographics and healthcare settings across regions and countries. Additionally, the prospective analysis may be affected by selection bias, as those non-returning patients who could not be reached might have provided meaningfully different answers.

WIDER IMPLICATIONS OF THE FINDINGS

These findings align with current literature while providing new insights into non-return for fertility treatment. The study underscores the need for tailored support and counseling to address the challenges faced by the couples, potentially enhancing treatment adherence and outcomes.

STUDY FUNDING/COMPETING INTEREST(S)

This research received no specific funding. The authors report no conflicts of interest.

TRIAL REGISTRATION NUMBER

clinicaltrials.gov NCT06344585.

Gottman's sound relationship house and relational resilience through infertility for couples

Some couples report that their relationship satisfaction increases through the experience of infertility. Few studies exist which explain how this phenomenon occurs through specific variables. We hypothesized that John Gottman's constructs of friendship and intimacy as well as shared meaning could explain how couples can achieve increased relationship satisfaction. We examined a regression analysis of cross-sectional retrospective individual data for couples who are either experiencing infertility currently or have done so in the recent past. In our nonclinical sample (n = 903), mediation analyses indicated significant influencing pathways for the Gottman shared meaning system, indicating that this construct may explain how couples achieve greater emotional bonding and couple satisfaction through infertility. These findings provide couple therapists with potential areas of focus for couples navigating infertility through the lens of Gottman Method Couple Therapy, including ways to encourage deeper mutual shared meaning amidst the infertility experience.

Pilot trial of a new self-directed psychological intervention for infertility-related distress

BACKGROUND

Now affecting one in six couples in Canada, infertility is defined as a lack of conception after 12 or more months of regular, unprotected heterosexual intercourse. Infertility is associated with immense psychological burden, particularly for individuals assigned female at birth. Yet existing psychological interventions are not specialized to this population and have been shown to be only marginally effective at relieving distress related to infertility. Thus, a new online self-directed psychological intervention was co-created with a panel of women experiencing infertility, and ultimately consisted of six 10-min video modules addressing the cognitive, emotional, and interpersonal aspects of infertility-related distress.

METHODS

In the current study, 21 women experiencing reduced quality of life related to infertility were recruited to participate in a one-arm pre-post pilot testing the feasibility, acceptability, and preliminary efficacy of the program. Participant adherence and retention were monitored, and participants rated the credibility of the program and the helpfulness of each module as well as provided feedback on the content and format of the program. Pre-to-post changes in fertility quality of life, anxious symptoms, depressive symptoms, and relationship satisfaction were examined.

RESULTS

The program modules were highly rated by participants, with average helpfulness ratings ranging from 7.5 to 8.2/10. Two participants became pregnant and therefore stopped prematurely, 79% of the remaining participants completed all six modules, and participants reported completing 52.8 (SD = 82.0) min of homework per week. Participants perceived the intervention as highly credible and generally approved of the format, length, and speed; however, 68% of participants had recommendations for additional content to be included in the intervention. While relationship satisfaction did not change significantly over time, large pre-to-post improvements in fertility quality of life, depression, and anxiety were observed (p < .001; Cohen's ds = 0.9-1.3).

CONCLUSIONS

This self-directed intervention was well received and has the potential to be highly effective in reducing infertility-related distress, informing future development and optimization.

TRIAL REGISTRATION

ClinicalTrials.gov, NCT05103982.

Implementation of a web-based partnership support program for improving the quality of life of male patients undergoing infertility treatment: a pilot feasibility study

OBJECTIVES

In this study, we aimed to implement and evaluate a Web-based partnership support program to enhance the QoL of male patients undergoing infertility treatment. We conducted a pilot study involving 41 infertile couples from September to October of 2021. We used a quasi-experimental design (pre-test and post-test with comparison) involving purposive sampling. A subgroup analysis was conducted to determine which demographics of the participants would benefit from the program.

RESULTS

Thirty-four participants (mean age 37.3 years; duration of infertility treatment 14.5 months) were included in the final analysis (follow-up rate 82.9%). Although there was no significant increase in the participants' QoL under the Web-based partnership support program, the assisted reproductive technology group (P = 0.03), the no medical history group (P = 0.032), and the with experience of changing hospital group (P = 0.027) showed a significant increase in the relational subscale scores of the QoL before and after the program. The majority of the participants (n = 29; 85.3%) expressed satisfaction with the support program. Participation in the Web-based partnership support program may improve the QoL of some men undergoing infertility treatment. Trial registration Retrospectively registered at the University Hospital Medical Information Network on 26 January 2023 (ID: UMIN0000 000050153).

Bedarfsorientierte kognitiv-behaviorale Intervention für Paare mit Infertilität (FERTIFIT): Eine Pilotstudie zur Entwicklung, Durchführbarkeit und Akzeptanz

Einleitung Weltweit schwankt die Prävalenz für Infertilität zwischen 4–17% und in westlichen Ländern ist rund eins von sieben Paaren mit Kinderwunsch betroffen. Das Erleben einer Infertilität ist mit einer erhöhten Wahrscheinlichkeit für psychische und partnerschaftliche Belastungen assoziiert, wobei sich Partner einer Paarbeziehung in ihrem Befinden gegenseitig beeinflussen. Dennoch ist die Versorgungslücke für betroffene Paare groß. In dieser Pilotstudie wird eine praktikabel umsetzbare, bedarfsorientierte und kognitiv-verhaltenstherapeutische Intervention für Paare mit Infertilität vorgestellt, die die partnerschaftliche Bewältigung typischer Problembereiche fördern und einer zunehmenden Belastung entgegenwirken soll.

Material und Methoden Insgesamt nahmen 21 heterosexuelle Paare an dieser Studie mit Eigen-Warte-Kontrollgruppendesign teil. Die Intervention beinhaltete bedarfsabhängig 5–10 paartherapeutische Sitzungen. Die psychische und infertilitätsbedingte Belastung, die Partnerschaftsqualität, sowie die Anwendung von individuellen und partnerschaftlichen Ressourcen wurden zu vier Messzeitpunkten (M1=vor Wartekontrollphase, M2=vor Intervention, M3=nach Intervention, M4=nach Katamnese) mittels Fragebögen erhoben.

Ergebnisse Bei Frauen besserten sich die psychische und infertilitätsbedingte Belastung, und sie griffen auf mehr Ressourcen zurück, die zum Wohlbefinden und zur aktiven Problembewältigung und Emotionsregulation beitragen. Während des Interventionszeitraumes kam es bei Männern zu einem zunehmenden Erleben hilfreicher Unterstützung, und sowohl bei Männern als auch bei Frauen zu einem häufigeren Einsatz partnerschaftlicher Copingstrategien. Die Evaluation zeigte, dass die Teilnehmenden sehr zufrieden waren mit der Intervention insgesamt und mit der erhaltenen Unterstützung.

Diskussion Die Befunde deuten auf eine gute Durchführbarkeit und Akzeptanz dieser Intervention in der psychotherapeutischen Praxis hin und liefern erste Hinweise auf mögliche erwünschte Effekte, die allerdings aufgrund des Studiendesigns und der vorliegenden Limitationen nicht eindeutig auf die Intervention zurückgeführt werden können.

Schlussfolgerung Die Stärke der vorliegenden Studie liegt in der Vorstellung eines in der psychotherapeutischen Praxis gut anwendbaren paartherapeutischen Konzepts, das bedarfsgerecht angeboten werden kann. Für die Überprüfung der gefundenen Effekte ist eine anschließende größer angelegte klinische Studie mit randomisiert-kontrolliertem Design notwendig.

Influence of a patient education and care program on women undergoing non-assisted reproductive technology fertility treatment

PURPOSE

To determine the influence of a patient education and care program on the quality of life (QOL) of female patients undergoing non-assisted reproductive technology (ART) fertility treatment.

METHODS

Participants completed the MOS 36-Item Short-Form Health Survey and fertility QOL (FertiQoL) questionnaires at baseline and at 3, 6, and 12 months of treatment. The responses of patients who underwent three sessions of the program (at baseline, 3 months, and 6 months of treatment) were compared with those of patients who did not receive the program.

RESULTS

This study compared 69 patients who received an additional care program with 104 patients in the control group, all from 13 facilities. Treatment FertiQoL responses (p = 0.004) and treatment tolerability (p = 0.043) differed between the program and control groups at 3 months using the repeated measures mixed model. The cost of treatment per pregnancy was lower in the program group than in the control group.

CONCLUSION

The patient education and care program provided by reproductive fertility specialists or fertility nurses during non-ART fertility programs improves patient satisfaction.

Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment

Assisted reproductive technology (ART) treatment accounted for 6% of total births in 2017 and is increasing which places Japan among the top worldwide in number of treatments performed. Although ART treatment patients often experience heavy physical and psychological burden, few epidemiologic studies have been conducted in Japan. We examined mental health and health-related quality of life (QOL) among women at early stages of treatment. We recruited 513 women who have initiated ART treatment, either in-vitro fertilization or intracytoplasmic sperm injection, from four medical facilities in the Tokyo area and through web-based approaches. At baseline, we collected socio-demographic information and assessed depressive symptoms, anxiety, and QOL. Descriptive analyses were performed overall and stratified by factors such as age. Mild depressive symptoms or worse, assessed with Quick Inventory of Depressive Symptoms, were observed among 54% of participants. Mean score for State-Trait Anxiety Inventory was 52 with a standard deviation of 11 for the state, and 39% were categorized as high anxiety. QOL results, assessed with SF-12, showed the same negative tendency for social functioning and role (emotional), while general health and physical functioning were consistent with the national average. Young participants appeared to suffer mentally more than older participants (p < 0.01 for depressive symptoms). Our findings suggest that patients may be at high risk of depressive symptoms, high anxiety, and low QOL even from the early stages of ART treatment.

Fertility quality of life tool: update on research and practice considerations

The 36-item Fertility Quality of Life (FertiQoL) tool is increasingly used in research and practice. It measures quality of life in four personal domains (emotional, social, relational, mind/body) and two treatment domains (tolerability, environment). A literature review of published empirical research using FertiQoL was undertaken to provide an overview of this research base. Five databases were searched using 'FertiQoL' and its variant. In total, 41 published articles from 35 independent samples in 23 countries involving 16,315 participants, mainly in clinical settings, were reviewed. FertiQoL was used for three main purposes: (i) to assess quality of life and FertiQoL measurement properties (especially Core FertiQoL) using cross-sectional designs; (ii) to identify correlates, predictors, and consequences of fertility quality of life (some of which included international comparisons); (iii) to assess the effect of psychological interventions on fertility quality of life. The range of median FertiQoL Core, Treatment and subscale (scaled) scores in 31 samples was between 60 and 75. Poorer fertility quality of life was consistently associated with being a woman, longer duration of infertility, poorer psychological functioning and lower patient-centred care. Some FertiQoL subscale scores improved after psychological interventions. Future research should address measurement issues and examine reported associations with fertility quality of life.

Quality-of-life predictors for men undergoing infertility treatment in Japan

AIM

To dentify the predictors of the quality of life (QOL) of infertile men who are undergoing infertility treatments in Japan and to create a QOL prediction model, with the main variables aimed at providing more adequate support to male patients.

METHODS

This cross-sectional study used the quantitative data that were collected from 321 returned self-report questionnaires that had been distributed to the men of 411 couples who were undergoing fertility treatment. The following four scales were used to measure the main outcomes: FertiQoL, psychological distress, spousal support, and workplace support. The data were analyzed by descriptive statistics, multiple regression analyses, and structural equation modeling.

RESULTS

The number of returned questionnaires was 321 (78.1%). The QOL that was measured by FertiQoL was significantly lower in those men who were diagnosed with male factor infertility than in the other male patients. The two significant predictors of QOL were: spousal support and the infertility period. The structural equation modeling revealed that the same factors were related to QOL.

CONCLUSIONS

Male factor infertility, less spousal support, and a longer period of infertility were associated with a poorer QOL of those men who were undergoing infertility treatment. These results suggest that focusing on infertility causes, the length of the infertility period, and the couples' partnership during treatment is needed to provide full support to men who have been diagnosed with infertility.

Administration of Oral Contraceptives Could Alleviate Age-Related Fertility Decline Possibly by Preventing Ovarian Damage in a Mouse Model

Age-related fertility decline is hypothesized to occur mainly by the spontaneous exhaustion and deterioration of the ovarian follicle, and the accumulation of ovarian tissue damage resulting from the ovulation cycle may play roles in the process. In this study, we hypothesized that suppressing ovulation would exert protective effects against age-related fertility decline. To test this hypothesis, we established a mouse model in which oral contraceptives (OCs) were administered daily. Female C57BL/6N mice were administered OCs daily from the age of 2 months to 12 months as an ovulation suppression mouse model. Mouse fecundity was investigated by counting oocyte number after ovarian stimulation and by examining live fetuses after mating. We found that compared with control mice administered vehicle alone, 12-month-old mice administered 2-fold dose OCs used for treating humans exhibited a significantly greater average oocyte number after ovarian stimulation (8.5 ± 0.6 vs 5.9 ± 0.6, P < .01). In addition, spontaneous conception with living fetuses after mating was strikingly increased in 12-month-old mice administered OCs relative to controls (6.0 ± 1.2 vs 0.4 ± 0.3, P < .01). In the histological examination of mouse ovarian tissues, we did not detect a significant difference in ovarian follicle number, but reduced amount of brownish foamy fibrous tissues, which might reflect ovarian tissue damage, was detected in aged mice administered OCs. These results suggest the possibility that long-term OC administration might alleviate age-related fertility decline, and the improvement mechanism could be attributed to the prevention of ovarian tissue damage by suppressing ovulation.

Quality of life in Turkish infertile couples and related factors

Infertility is a major life crisis affecting couples' psychosocial and physical health. We aimed to assess the quality of life in Turkish infertile couples. This cross-sectional survey was carried out in 127 infertile couples admitted to a University Hospital. The quality of life was measured using the fertility quality of life tool (FertiQoL) scale. Women had lower overall quality of life than men. Women and men who were married for fewer than 10 years had a significantly lower emotional score. Women who had a history of infertility treatment, men who have lived in the town or village men with primary infertility and men who have had primary education or lower, had lower scores for mind/body subscale. Social scores were found lower in women under the age of 30, women with middle or low income, men who were married for fewer than 10 years, men who did not have children for 5 years or more and men with primary infertility. The tolerability and environment scores were significantly higher in women who had been married more than once. We conclude that health care providers should be aware of the factors affecting the quality of life (QoL) and give counselling to improve couples' quality of life at infertility clinics.

A review of patient-reported outcome measures to assess female infertility-related quality of life

BACKGROUND

Infertility has a negative impact on quality of life (QoL) and well-being of affected individuals and couples. A variety of patient-reported outcome (PRO) measures to assess infertility-related QoL are available; however, there is a concern regarding potential issues with their development methodology, validation and use. This review aimed to i) identify PRO measures used in infertility interventional studies ii) assess validation evidence to identify a reliable, valid PRO measure to assess changes in QoL or treatment satisfaction in clinical studies with female patients following treatment with novel therapies iii) identify potential gaps in evidence for validity.

METHODS

A structured literature search of Medline, Embase, and the Cochrane Library (accessed in September 2015) was conducted using pre-defined search terms. The identified publications were reviewed applying eligibility criteria to select interventional female infertility studies using PROs. Infertility-specific PRO measures assessing QoL, treatment satisfaction or psychiatric health, and included in studies by ≥2 research groups were selected and critically reviewed in light of scientific and regulatory guidance (e.g. FDA PRO Guidance for Industry) for evidence of content validity, psychometric strength, and patient acceptability.

RESULTS

The literature search and hand-searching yielded 122 publications; 78 unique PRO measures assessing QoL, treatment satisfaction or psychiatric health were identified. Five PRO measures met the selection criteria for detailed review: Fertility Quality of Life (FertiQoL); Fertility Problem Inventory (FPI); Fertility Problem Stress (FPS); Infertility Questionnaire (IFQ); Illness Cognitions Questionnaire adapted for Infertility (ICQ-I). None of the PRO measures met all validation criteria. The FertiQoL was the most widely used infertility-specific PRO measure to assess QoL in interventional studies, with reasonable evidence for adequate content validity, psychometric strength, and linguistic validation. However, gaps in evidence remain including test-retest reliability and thresholds for interpreting clinically important changes. While the FPI demonstrated reasonable evidence for content and psychometric validity, its utility as an outcome measure is limited by a lack of recall period.

CONCLUSION

The FertiQoL and the FPI are potentially useful measures of infertility-related QoL in interventional studies. Further research is recommended to address gaps in evidence and confirm both PRO measures as reliable assessments of patient outcomes.